Department of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo. Department of Epidemiology and Biostatistics, School of Integrated Health Sciences, Faculty of Medicine, The University of Tokyo.

Paper (English)

Hashimoto Y, Iwagami M, Yamana H, Ono S, Takeuchi Y, Michihata N, Uemura K, Aihara M, Yasunaga H. Ocular adverse events after influenza vaccination in older adults: self-controlled case series using a large database in Japan. Ophthalmic Epidemiol, Online ahead of print 2023 Dec.
Takeuchi Y, Hagiwara Y, Komukai S, Matsuyama Y. Estimation of the causal effects of time-varying treatments in nested case-control studies using marginal structural Cox models. Biometrics. 2024;80:ujae005.
Taira N, Kikawa Y, Iwamoto T, Miyoshi Y, Hara K, Yoshitomi S, Hikino H, Takahashi H, Takabatake D, Kubo S, Ikeda M, Doihara H, Shien T, Okuyama H, Tanabe Y, Hara F, Yamanouchi K, Hagiwara Y, Sawaki M. Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy. Breast Cancer. 2024. doi: 10.1007/s12282-023-01537-3. Online ahead of print.
Yamawaki M, Murasato Y, Watanabe Y, Kinoshita Y, Okubo M, Yumoto K, Masuda N, Otake H, Aoki J, Nakazawa G, Numasawa Y, Ito T, Shite J, Okamura T, Takagi K, Kozuma K, Lefèvre T, Chevalier B, Louvard Y, Suzuki N, Kozuma K. Impact of coronary bifurcation angle on stent malapposition in a randomized comparison between proximal optimization technique followed by side branch dilatation and kissing balloon inflation. Int J Cardiol Heart Vasc. 2023 Aug 29;48:101265. doi: 10.1016/j.ijcha.2023.101265. eCollection 2023 Oct.
Watanabe J, Kagawa Y, Chida K, et al. Phase III trial of short-course radiotherapy followed by CAPOXIRI versus CAPOX in locally advanced rectal cancer: the ENSEMBLE trial. ESMO Gastrointestinal Oncology. 2023;1:9-14.
Fukuda M, Sakamaki K, Oba K. The net benefit for time-to-event outcome in oncology clinical trials with treatment switching. Clin Trials. 2023 Jul 16:17407745231186081. doi: 10.1177/17407745231186081
Takada M, Imoto S, Ishida T, Ito Y, Iwata H, Masuda N, Mukai H, Saji S, Ikeda T, Haga H, Saeki T, Aogi K, Sugie T, Ueno T, Ohno S, Ishiguro H, Kanbayashi C, Miyamoto T, Hagiwara Y, Toi M. A risk-based subgroup analysis of the effect of adjuvant S-1 in estrogen receptor-positive, HER2-negative early breast cancer. Breast Cancer Res Treat. 2023. doi: 10.1007/s10549-023-07099-4. Online ahead of print.
Hashimoto Y, Yamana H, Iwagami M, Ono S, Takeuchi Y, Michihata N, Uemura K, Yasunaga H, Aihara M, Kaburaki T. Ocular adverse events after COVID-19 mRNA vaccination: matched cohort and self-controlled case series studies using a large database. Ophthalmology. 130(3) 256-264 2023 Mar.
Shibuta T, Waki K, Miyake K, Igarashi A, Yamamoto-Mitani N, Sankoda A, Takeuchi Y, Sumitani M, Yamauchi T, Nangaku M, Ohe K. Preliminary efficacy, feasibility, and perceived usefulness of a smartphone-based self-management system with personalized goal setting and feedback to increase step count among workers with high blood pressure: Before-after study. JMIR Cardio. 7 e43940 2023 Jul.
Yokoyama R, Takeuchi Y, Kumamaru H, Matsuyama Y. The utility of the self-controlled study design for pharmacoepidemiological studies without an active comparator medication using a medical information database: An application to assess the risk of varenicline on cardiovascular outcomes. Pharmacoepidemiol Drug Saf. 32(10) 1068-1076 2023 Oct.
Fukuhara H, Hagiwara Y, Oba K, Inoue K. Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (3rd report): cost impact of transurethral resection of bladder tumor in Japan. Photodiagnosis Photodyn Ther. 2023;103758. doi: 10.1016/j.pdpdt.2023.103758.
Hagiwara Y. Using a sample size calculation framework for clinical prediction models when developing and selecting mapping algorithms based on linear regression. Med Decis Making. 2023. doi: 10.1177/0272989X231188134. Online ahead of print.
Suzuki Y, Iwamoto T, Uno M, Hatono M, Kajiwara Y, Takahashi Y, Kochi M, Shien T, Kikawa Y, Uemura Y, Hagiwara Y, Yamamoto S, Taira N, Doihara H, Toyooka S. Development and validation of a symptom illustration scale from the patient-reported outcome common terminology criteria for adverse events for patients with breast cancer. Breast Cancer. 2023. doi: 10.1007/s12282-023-01480-3. Online ahead of print.
Mayanagi S, Oba K, Aoyama T, Tanaka K, Kanda M, Honda M, Maeda H, Kashiwabara K, Muto M, Sakamoto J, Yamagishi H, Yoshikawa T. Feasibility and Safety of Adjuvant Chemotherapy for Resected Colorectal Cancer in Patients With Renal Insufficiency: A Pooled Analysis of Individual Patient Data from Five Japanese Large-scale Clinical Trials. Anticancer Res. 2023 Jul;43(7):3089-3095. doi: 10.21873/anticanres.16480
Sankoda A, Nagae Y, Waki K, Sze WT, Oba K, Mieno M, Nangaku M, Yamauchi T, Ohe K. Glycemic control, renal progression, and usage of telemedicine phone consultations among Japanese type 2 diabetes mellitus patients during the COVID-19 pandemic: a retrospective cohort study. JMIR Diabetes. 2023 May 24. doi: 10.2196/42607
Tsubono K, Oba K, Fudetani Y, Ikeda C, Sakamoto J. Multidimensional analysis of schoolteachers' occupational stress by the New Brief Job Stress Questionnaire: focusing on gender differences. Ind Health. 2023 May 26. doi: 10.2486/indhealth.2023-0018
Abe S, Kawai K, Nozawa H, Sasaki K, Murono K, Emoto S, Yokoyama Y, Matsuzaki H, Nagai Y, Yoshioka Y, Shinagawa T, Sonoda H, Yamamoto Y, Oba K, Ishihara S. Preoperative chemoradiotherapy using tegafur/uracil, oral leucovorin, and irinotecan (TEGAFIRI) followed by oxaliplatin-based chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: the study protocol for a phase II trial. BMC Cancer. 2023 May 17;23(1):450. doi: 10.1186/s12885-023-10941-z
Aoyama T, Oba K, Honda M, Muto M, Mayanagi S, Maeda H, Kanda M, Kashiwabara K, Sakamoto J, Yoshikawa T. The clinical impacts of postoperative complications after colon cancer surgery for the clinical course of adjuvant treatment and survival. Int J Clin Oncol. 2023 Jun;28(6):777-784. doi: 10.1007/s10147-023-02332-y
Fuyama K, Ogawa M, Mizusawa J, Kanemitsu Y, Fujita S, Kawahara T, Sakamaki K, Oba K. Impact of correlations between prioritized outcomes on the net benefit and its estimate by generalized pairwise comparisons. Stat Med. 2023 May 10;42(10):1606-1624. doi: 10.1002/sim.9690.
Yoshida C, Yamaguchi H, Doki N, Murai K, Iino M, Hatta Y, Onizuka M, Yokose N, Fujimaki K, Hagihara M, Oshikawa G, Murayama K, Kumagai T, Kimura S, Najima Y, Iriyama N, Tsutsumi I, Oba K, Kojima H, Sakamaki H, Inokuchi K; Kanto CML Study Group. Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study. Int J Hematol. 2023 May;117(5):694-705. doi: 10.1007/s12185-023-03549-3.